Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheena Gupta

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2016
Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsetsJohn F Ryan, Rachel Hovde, Jacob Glanville, et al.
Frontiers in Allergy|August 6, 2025
Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIFShirley Y Jiang, Shu Cao, Kristine Martinez, et al.
Nature Communications|November 5, 2022
CD8<sup>+</sup> T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapyAbhinav Kaushik, Diane Dunham, Xiaorui Han, et al.
Allergy|March 30, 2021
Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumabMonali Manohar, Diane Dunham, Sheena Gupta, et al.
Frontiers in Immunology|November 7, 2025
Trends in allergen-reactive CRTH2+ T cells and TARC associated with successful outcomes in a phase 2 cashew oral immunotherapy studySayantani B Sindher, Andrea Fernandes, Monali Manohar, et al.
Science Immunology|April 5, 2024
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humansLilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Research Square|May 20, 2021
Systems biological assessment of human immunity to BNT162b2 mRNA vaccinationPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.
Nature|July 12, 2021
Systems vaccinology of the BNT162b2 mRNA vaccine in humansPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2016
Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsetsJohn F Ryan, Rachel Hovde, Jacob Glanville, et al.
Frontiers in Allergy|August 6, 2025
Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIFShirley Y Jiang, Shu Cao, Kristine Martinez, et al.
Nature Communications|November 5, 2022
CD8<sup>+</sup> T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapyAbhinav Kaushik, Diane Dunham, Xiaorui Han, et al.
Allergy|March 30, 2021
Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumabMonali Manohar, Diane Dunham, Sheena Gupta, et al.
Frontiers in Immunology|November 7, 2025
Trends in allergen-reactive CRTH2+ T cells and TARC associated with successful outcomes in a phase 2 cashew oral immunotherapy studySayantani B Sindher, Andrea Fernandes, Monali Manohar, et al.
Science Immunology|April 5, 2024
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humansLilit Grigoryan, Yupeng Feng, Lorenza Bellusci, et al.
Research Square|May 20, 2021
Systems biological assessment of human immunity to BNT162b2 mRNA vaccinationPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.
Nature|July 12, 2021
Systems vaccinology of the BNT162b2 mRNA vaccine in humansPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.
Pageof 2